Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Rapport Therapeutics Stock

Q: Can you buy Rapport Therapeutics stock?

You can no longer buy Rapport Therapeuticsstock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

rapportrx.comHealthcare / Healthcare softwareFounded: 2022Funding to Date: $250.18MM

Rapport Therapeutics is dedicated to crafting precision medicines tailored to the complexity of the human brain, marking a significant stride in the field of neuro medicines. Emphasizing a scientific partnership approach, they deliver revolutionary, relentless, and precise treatments. Their mission is to address neurological complexities with unmatched accuracy, leveraging cutting-edge research and development to create therapies that accurately match the nuanced needs of individuals.

Learn more about Rapport Therapeutics IPO

Enterprise Value

Access valuation and stock price for companies like Rapport Therapeutics before its IPO.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Rapport Therapeutics stock FAQs

Can you buy Rapport Therapeutics stock?

You can no longer buy Rapport Therapeutics stock on a secondary marketplace as this company is no longer private. If you are interested in buying stock of other private companies, learn more about how to invest in the private market or register today to get started.

How to buy Rapport Therapeutics stock?

To invest in a private company like Rapport Therapeutics through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Rapport Therapeutics stock?

You can no longer sell stock of Rapport Therapeutics on Forge as this company is no longer private. However, if you own stock of a private company, Forge may help you sell it in a way that works for you and the company. Learn more or register with us today to get started.

How to sell Rapport Therapeutics stock?

If you hold private company shares of Rapport Therapeutics - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Rapport Therapeutics stock on our platform.
Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

Is Rapport Therapeutics a public company?

No, Rapport Therapeutics is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Rapport Therapeutics’ stock ticker symbol?

The ticker symbol of Rapport Therapeutics is RAPP.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Featured

Startup News: Three cutting-edge companies file for IPO

Learn More

Renaissance Capital 06/03/2024

CNS disorder biotech Rapport Therapeutics sets terms for $136 million IPO

Rapport is setting the stage for a potential public offering.

Reuters 05/17/2024

J&J-backed startup Rapport files for US IPO

Rapport Therapeutics announced its recent IPO filing.

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.